The Bleeding Disorders Therapeutics Market is witnessing significant expansion as a result of the rising prevalence of inherited and acquired bleeding disorders, growing awareness about early diagnosis, and rapid advancements in recombinant and plasma-derived therapies. Bleeding disorders such as hemophilia A, hemophilia B, and von Willebrand disease require long-term and often lifelong...